BioMotiv and Biogen Form Strategic Partnership in Neuroscience

/EINPresswire.com/ — CLEVELAND, OH — (Marketwired) — 09/21/15 — BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development centered at University Hospitals in Cleveland, Ohio, announced today that it has entered into a strategic partnership with Biogen. This discovery collaboration will leverage the strengths of both organizations to identify pioneering neuroscience discoveries and advance them into medicines. Biogen has committed to invest $15 million in BioMotiv over five years, providing Biogen with exclusive rights relating to neuroscience programs sourced and developed by BioMotiv. “Biogen is the leading company for developing novel neuroscience therapeutics,” said Baiju R. Shah, Chief Executive Officer of BioMotiv. “This partnership completes a platform to advance novel medicines that address some of the most complex medical challenges.” BioMotiv is the for-profit…


Link to Full Article: BioMotiv and Biogen Form Strategic Partnership in Neuroscience